WIESBADEN, Germany, March 30, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has obtained CE Marking (Conformite Europeene) in the European Union to market its rapid, high-throughput

ABBOTT PARK, Ill., Feb.

ABBOTT PARK, Ill., Aug. 10, 2011 /PRNewswire/ -- Abbott's Ibis Biosciences today introduced a new molecular assay to detect a wide variety of vector-borne microorganisms, including those known to cause Lyme Disease, Rocky Mountain Spotted Fever, Babesiosis, Ehrlichiosis and Anaplasmosis.

WASHINGTON, Feb.

CARLSBAD, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its financial results for the third quarter ended September 30, 2009. For the quarter, Isis reported a net loss of $3.4 million and a net operating loss of $6.9 million.